These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17371230)

  • 1. Role of PTEN/PI3K pathway in endothelial cells.
    Suzuki A; Hamada K; Sasaki T; Mak TW; Nakano T
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):172-6. PubMed ID: 17371230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
    Dey N; Crosswell HE; De P; Parsons R; Peng Q; Su JD; Durden DL
    Cancer Res; 2008 Mar; 68(6):1862-71. PubMed ID: 18339867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac regulation by phosphoinositide 3-kinases and PTEN.
    Oudit GY; Penninger JM
    Cardiovasc Res; 2009 May; 82(2):250-60. PubMed ID: 19147653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase.
    Barber DF; Alvarado-Kristensson M; González-García A; Pulido R; Carrera AC
    Sci STKE; 2006 Nov; 2006(362):pe49. PubMed ID: 17119157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of Pten in osteo-chondroprogenitor cells leads to epiphyseal growth plate abnormalities and skeletal overgrowth.
    Ford-Hutchinson AF; Ali Z; Lines SE; Hallgrímsson B; Boyd SK; Jirik FR
    J Bone Miner Res; 2007 Aug; 22(8):1245-59. PubMed ID: 17456009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN.
    Andrés-Pons A; Rodríguez-Escudero I; Gil A; Blanco A; Vega A; Molina M; Pulido R; Cid VJ
    Cancer Res; 2007 Oct; 67(20):9731-9. PubMed ID: 17942903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas.
    Hernando E; Charytonowicz E; Dudas ME; Menendez S; Matushansky I; Mills J; Socci ND; Behrendt N; Ma L; Maki RG; Pandolfi PP; Cordon-Cardo C
    Nat Med; 2007 Jun; 13(6):748-53. PubMed ID: 17496901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TGF-beta, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer.
    Assinder SJ; Dong Q; Kovacevic Z; Richardson DR
    Biochem J; 2009 Jan; 417(2):411-21. PubMed ID: 19099539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis.
    Hamada K; Sasaki T; Koni PA; Natsui M; Kishimoto H; Sasaki J; Yajima N; Horie Y; Hasegawa G; Naito M; Miyazaki J; Suda T; Itoh H; Nakao K; Mak TW; Nakano T; Suzuki A
    Genes Dev; 2005 Sep; 19(17):2054-65. PubMed ID: 16107612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.
    Hoeflich KP; O'Brien C; Boyd Z; Cavet G; Guerrero S; Jung K; Januario T; Savage H; Punnoose E; Truong T; Zhou W; Berry L; Murray L; Amler L; Belvin M; Friedman LS; Lackner MR
    Clin Cancer Res; 2009 Jul; 15(14):4649-64. PubMed ID: 19567590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN mutation: many birds with one stone in tumorigenesis.
    Liu W; Zhou Y; Reske SN; Shen C
    Anticancer Res; 2008; 28(6A):3613-9. PubMed ID: 19189642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple roles for the p85α isoform in the regulation and function of PI3K signalling and receptor trafficking.
    Mellor P; Furber LA; Nyarko JN; Anderson DH
    Biochem J; 2012 Jan; 441(1):23-37. PubMed ID: 22168437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention.
    Zhang J; Grindley JC; Yin T; Jayasinghe S; He XC; Ross JT; Haug JS; Rupp D; Porter-Westpfahl KS; Wiedemann LM; Wu H; Li L
    Nature; 2006 May; 441(7092):518-22. PubMed ID: 16633340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3 kinases in cancer: from oncogene artifact to leading cancer target.
    Zhao JJ; Roberts TM
    Sci STKE; 2006 Dec; 2006(365):pe52. PubMed ID: 17164467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis.
    Cully M; You H; Levine AJ; Mak TW
    Nat Rev Cancer; 2006 Mar; 6(3):184-92. PubMed ID: 16453012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple colon carcinomas in a patient with Cowden syndrome.
    Bosserhoff AK; Grussendorf-Conen EI; Rübben A; Rudnik-Schöneborn S; Zerres K; Buettner R; Merkelbach-Bruse S
    Int J Mol Med; 2006 Oct; 18(4):643-7. PubMed ID: 16964417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.
    Rodríguez-Escudero I; Oliver MD; Andrés-Pons A; Molina M; Cid VJ; Pulido R
    Hum Mol Genet; 2011 Nov; 20(21):4132-42. PubMed ID: 21828076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis.
    Yeager N; Klein-Szanto A; Kimura S; Di Cristofano A
    Cancer Res; 2007 Feb; 67(3):959-66. PubMed ID: 17283127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN: tumour suppressor, multifunctional growth regulator and more.
    Goberdhan DC; Wilson C
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R239-48. PubMed ID: 12928488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inherited PTEN mutations and the prediction of phenotype.
    Leslie NR; Longy M
    Semin Cell Dev Biol; 2016 Apr; 52():30-8. PubMed ID: 26827793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.